GSK boosts plant job cuts by 20

GlaxoSmithKline has tagged as redundant another 20 positions at its Ulverston, UK, manufacturing plant. The cuts were scheduled to be made Monday.

The plant has been under renovation at the same time the staff cuts were announced. The 2008 plan calls for an existing staff of 540 to be cut to less than 250. To make the cuts possible, GSK planned to outsource some intermediates manufacturing and update the plant and equipment. Ulverston was to retain its "specialist sterile manufacture and oral spraying technologies," according to a UK press report.

The number of cuts would have been higher. But some have been forestalled by production issues stemming from bad winter weather and a delayed product development contract.

- here's the article


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.